Alan Spatz

Alan Spatz

McGill University - Montréal / Canada
Medical and Health Sciences / Pathology
AD Scientific Index ID: 642362
person_outline Alan Spatz's MOST POPULAR ARTICLES
1-) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialB Escudier, T Dorval, N Chaput, F André, MP Caby, S Novault, C Flament, ...Journal of translational medicine 3 (1), 1-13, 200511452005
2-) Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trialAMM Eggermont, S Suciu, M Santinami, A Testori, WHJ Kruit, J Marsden, ...The Lancet 372 (9633), 117-126, 20087082008
3-) Cutaneous melanomaAMM Eggermont, A Spatz, C RobertThe Lancet 383 (9919), 816-827, 20146762014
4-) Cutaneous side-effects of kinase inhibitors and blocking antibodiesC Robert, JC Soria, A Spatz, A Le Cesne, D Malka, P Pautier, J Wechsler, ...The lancet oncology 6 (7), 491-500, 20056972005
5-) Gene expression profiling of primary cutaneous melanoma and clinical outcomeV Winnepenninckx, V Lazar, S Michiels, P Dessen, M Stas, SR Alonso, ...Journal of the National Cancer Institute 98 (7), 472-482, 20065612006